Position in TRVI
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$44,288,609
-$2,871,088 QoQ
Shares Held
3,712,373
-1.4% QoQ
Ownership
2.61%
of shares outstanding
% of Portfolio
0.56%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2022
16 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in TRVI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Rubric Capital Management LP holds $938,577,278 across 18 Biotechnology names. TRVI ranks #8 (4.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARQT |
Arcutis Biotherapeutics, Inc.
|
8,271,577 | $194,878,354 | |
| 2 | ZYME |
Zymeworks Inc.
|
7,000,000 | $175,280,000 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
5,000,000 | $138,500,000 | |
| 4 | SPRY |
ARS Pharmaceuticals, Inc.
|
8,000,000 | $64,240,000 | |
| 5 | MGTX |
MeiraGTx Holdings plc
|
7,000,000 | $60,620,000 | |
| 6 | PRTA |
Prothena Corp Public Ltd Co
|
5,000,000 | $48,600,000 | |
| 7 | PTGX |
Protagonist Therapeutics, Inc
|
427,998 | $45,110,989 | |
| 8 | TRVI |
Trevi Therapeutics, Inc.
This page
|
3,712,373 | $44,288,609 |
All Filings in TRVI
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $44,288,609 | 3,712,373 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $47,159,697 | 3,766,749 | Shares | Sole | 2026-02-13 | |
| 2025-12-31 | $47,159,697 | 3,766,749 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $78,066,519 | 8,531,860 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $46,669,274 | 8,531,860 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $28,547,385 | 4,538,535 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $17,325,131 | 4,205,129 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $16,789,949 | 5,026,931 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $14,980,254 | 5,026,931 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $19,196,224 | 5,564,123 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $7,617,122 | 5,684,420 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $12,392,035 | 5,684,420 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $13,585,763 | 5,684,420 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $10,516,177 | 5,684,420 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $10,970,930 | 5,684,420 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $8,754,006 | 5,684,420 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $4,997,360 | 1,778,420 | Shares | Sole | 2022-08-15 | |
| No filing history on record for this holder in this stock. | ||||||